Muhammad Arshad

710 total citations
36 papers, 507 citations indexed

About

Muhammad Arshad is a scholar working on Epidemiology, Molecular Biology and Hematology. According to data from OpenAlex, Muhammad Arshad has authored 36 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 9 papers in Molecular Biology and 7 papers in Hematology. Recurrent topics in Muhammad Arshad's work include Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (6 papers) and Blood groups and transfusion (4 papers). Muhammad Arshad is often cited by papers focused on Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (6 papers) and Blood groups and transfusion (4 papers). Muhammad Arshad collaborates with scholars based in Pakistan, United States and Saudi Arabia. Muhammad Arshad's co-authors include Usman Waheed, Abida Arshad, Shatha A. Alduraywish, Fahad M. Aldakheel, Muhammad Hassan Raza, Sami Siraj, Delong Liu, Anila Qureshi, Karen Seiter and Naveeda Riaz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Muhammad Arshad

34 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muhammad Arshad Pakistan 8 201 90 63 51 42 36 507
Dina Johar Egypt 14 224 1.1× 105 1.2× 61 1.0× 32 0.6× 72 1.7× 28 557
Noureldien H. E. Darwish United States 14 246 1.2× 109 1.2× 33 0.5× 69 1.4× 59 1.4× 36 621
Meifang Wang China 13 228 1.1× 67 0.7× 41 0.7× 122 2.4× 74 1.8× 40 593
Kamila Balušíková Czechia 14 187 0.9× 104 1.2× 35 0.6× 41 0.8× 62 1.5× 20 462
You Li China 12 250 1.2× 43 0.5× 62 1.0× 89 1.7× 46 1.1× 29 598
Richard D. Horniblow United Kingdom 10 184 0.9× 67 0.7× 73 1.2× 13 0.3× 28 0.7× 20 458
Qing Guo China 14 205 1.0× 76 0.8× 32 0.5× 38 0.7× 64 1.5× 30 570
Nina Grossmann Germany 8 340 1.7× 101 1.1× 58 0.9× 25 0.5× 69 1.6× 9 622
Bin Wen China 14 296 1.5× 50 0.6× 51 0.8× 43 0.8× 49 1.2× 36 523
Yaghoub Yazdani Iran 15 427 2.1× 113 1.3× 50 0.8× 65 1.3× 153 3.6× 47 885

Countries citing papers authored by Muhammad Arshad

Since Specialization
Citations

This map shows the geographic impact of Muhammad Arshad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Arshad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Arshad more than expected).

Fields of papers citing papers by Muhammad Arshad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad Arshad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Arshad. The network helps show where Muhammad Arshad may publish in the future.

Co-authorship network of co-authors of Muhammad Arshad

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Arshad. A scholar is included among the top collaborators of Muhammad Arshad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Arshad. Muhammad Arshad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Chunhai, B. Zhang, Xing Han, et al.. (2025). To explore the potential combined treatment strategy for colorectal cancer: Inhibition of cancer stem cells and enhancement of intestinal immune microenvironment. European Journal of Pharmacology. 998. 177533–177533. 3 indexed citations
2.
Han, Xing, B. Zhang, Mingwei Ma, et al.. (2024). Suppressed oncogenic molecules involved in the treatment of colorectal cancer by fecal microbiota transplantation. Frontiers in Microbiology. 15. 1451303–1451303. 2 indexed citations
3.
Arshad, Muhammad. (2023). 68P Neratinib in combination with fulvestrant and or palbociclib can overcome endocrine resistance in HER2-low/ ER+ breast cancer. Annals of Oncology. 34. S1491–S1492. 1 indexed citations
4.
Bashir, Shahid, Turki Abualait, Muhammad Arshad, et al.. (2022). Effects of transcranial magnetic stimulation on neurobiological changes in Alzheimer's disease (Review). Molecular Medicine Reports. 25(4). 24 indexed citations
5.
Waheed, Usman, et al.. (2021). Molecular and genetic characterization of hepatitis B virus among multitransfused thalassaemia patients in Islamabad, Pakistan. SHILAP Revista de lepidopterología. 10(2). 998–1002. 3 indexed citations
6.
7.
Khan, Sanaullah, et al.. (2020). Pre-existing resistance associated polymorphisms to NS3 protease inhibitors in treatment naïve HCV positive Pakistani patients. PLoS ONE. 15(4). e0231480–e0231480. 3 indexed citations
8.
Khan, Sanaullah, Muhammad Arshad, Syed Ishtiaq Anjum, et al.. (2020). Peripheral blood T cells response in human parainfluenza virus-associated lower respiratory tract infection in children. Saudi Journal of Biological Sciences. 27(10). 2847–2852. 3 indexed citations
9.
Waheed, Usman, et al.. (2019). Spectrum of alloimmunization among multitransfused beta-thalassemia major patients. SHILAP Revista de lepidopterología. 4(1). 39–39. 5 indexed citations
10.
Waheed, Usman, et al.. (2019). Evaluation of the automated fluorescent immunoassay system anti-hepatitis C virus assay for the detection of hepatitis C virus infection. SHILAP Revista de lepidopterología. 4(2). 198–198. 1 indexed citations
11.
Raza, Muhammad Hassan, Abida Arshad, Naveeda Riaz, et al.. (2018). Microbiota in cancer development and treatment. Journal of Cancer Research and Clinical Oncology. 145(1). 49–63. 72 indexed citations
12.
Saeed, Muhammad, et al.. (2018). Acinetobacter Spp: Resistance and therapeutic decisions at the turn of the novel millennium.. PubMed. 31(6 (Supplementary). 2749–2754. 1 indexed citations
13.
Waheed, Usman, et al.. (2018). Red blood cell phenotyping of blood donors in Islamabad, Pakistan. SHILAP Revista de lepidopterología. 3(1). 26–26. 3 indexed citations
14.
Raza, Muhammad Hassan, Sami Siraj, Abida Arshad, et al.. (2017). ROS-modulated therapeutic approaches in cancer treatment. Journal of Cancer Research and Clinical Oncology. 143(9). 1789–1809. 226 indexed citations
15.
Waheed, Usman, et al.. (2017). Detection of HBsAg mutants in the blood donor population of Pakistan. PLoS ONE. 12(11). e0188066–e0188066. 10 indexed citations
16.
Shaheen, Ghazala, et al.. (2011). EFFECTS OF BREAST CANCER ON PHYSIOLOGICAL AND PSYCHOLOGICAL HEALTH OF PATIENTS. 2 indexed citations
17.
Seiter, Karen, Delong Liu, Eric J. Feldman, et al.. (2006). Long-term follow-up of high-dose mitoxantrone-based induction therapy for patients with newly-diagnosed acute myelogenous leukemia. Twelve year results from a single institution. Leukemia & lymphoma. 47(3). 425–432. 5 indexed citations
18.
Arshad, Muhammad, et al.. (2006). Thromboxane Receptor Stimulation Suppresses Guanylate Cyclase-Mediated Relaxation of Radial Arteries. The Annals of Thoracic Surgery. 81(6). 2147–2154. 27 indexed citations
19.
Seiter, Karen, Anila Qureshi, Delong Liu, et al.. (2005). Severe toxicity following induction chemotherapy for acute myelogenous leukemia in a patient with Werner's syndrome. Leukemia & lymphoma. 46(7). 1091–1095. 11 indexed citations
20.
Jaffar, M. Arfan, et al.. (2003). Reduced duration of muscle relaxation with rocuronium in a normocalcemic hyperparathyroid patient. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 50(6). 558–561. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dina Johar Breakdown of academic impact, for papers by Noureldien H. E. Darwish Breakdown of academic impact, for papers by Meifang Wang Breakdown of academic impact, for papers by Kamila Balušíková Breakdown of academic impact, for papers by You Li Breakdown of academic impact, for papers by Richard D. Horniblow Breakdown of academic impact, for papers by Qing Guo Breakdown of academic impact, for papers by Nina Grossmann Breakdown of academic impact, for papers by Bin Wen Breakdown of academic impact, for papers by Yaghoub Yazdani
Rankless by CCL
2026